DE60035191T2 - Materialien und methoden zur entwicklung von dopaminergen neuronen - Google Patents

Materialien und methoden zur entwicklung von dopaminergen neuronen Download PDF

Info

Publication number
DE60035191T2
DE60035191T2 DE60035191T DE60035191T DE60035191T2 DE 60035191 T2 DE60035191 T2 DE 60035191T2 DE 60035191 T DE60035191 T DE 60035191T DE 60035191 T DE60035191 T DE 60035191T DE 60035191 T2 DE60035191 T2 DE 60035191T2
Authority
DE
Germany
Prior art keywords
cells
nurr1
cell
dopaminergic
neural stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60035191T
Other languages
German (de)
English (en)
Other versions
DE60035191D1 (de
Inventor
Ernest Lab. of Mole ARENAS
Thomas The Ludwig I PERLMANN
Evan Y. Dep. of Neur 320 Longwood Avenue Boston SNYDER
Joseph Lab. of Mole WAGNER
Peter Lab of Molec AKERUD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NeuroTherapeutics AB
Original Assignee
NeuroTherapeutics AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NeuroTherapeutics AB filed Critical NeuroTherapeutics AB
Application granted granted Critical
Publication of DE60035191D1 publication Critical patent/DE60035191D1/de
Publication of DE60035191T2 publication Critical patent/DE60035191T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE60035191T 1999-05-03 2000-04-27 Materialien und methoden zur entwicklung von dopaminergen neuronen Expired - Fee Related DE60035191T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13231799P 1999-05-03 1999-05-03
US132317P 1999-05-03
PCT/EP2000/003842 WO2000066713A2 (en) 1999-05-03 2000-04-27 Materials and methods relating to neuronal development

Publications (2)

Publication Number Publication Date
DE60035191D1 DE60035191D1 (de) 2007-07-26
DE60035191T2 true DE60035191T2 (de) 2008-06-19

Family

ID=22453462

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035191T Expired - Fee Related DE60035191T2 (de) 1999-05-03 2000-04-27 Materialien und methoden zur entwicklung von dopaminergen neuronen

Country Status (10)

Country Link
US (1) US7465582B1 (https=)
EP (1) EP1173548B1 (https=)
JP (1) JP2002542818A (https=)
AT (1) ATE364688T1 (https=)
AU (1) AU4752700A (https=)
CA (1) CA2371260A1 (https=)
DE (1) DE60035191T2 (https=)
DK (1) DK1173548T3 (https=)
ES (1) ES2290032T3 (https=)
WO (1) WO2000066713A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129034B2 (en) 2001-10-25 2006-10-31 Cedars-Sinai Medical Center Differentiation of whole bone marrow
JP2005507927A (ja) * 2001-10-30 2005-03-24 バイオジェン・アイデック・エムエイ・インコーポレイテッド パーキンソン病を処置するための方法および組成物
EP1511839A4 (en) * 2002-06-05 2005-11-16 Es Cell Int Pte Ltd GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENCED HUMAN EMBRYONAL STEM CELLS
US20060233771A1 (en) * 2002-09-24 2006-10-19 Ernesto Arenas Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
KR20040079669A (ko) * 2003-03-10 2004-09-16 학교법인 한양학원 Ｎｕｒｒ1 과발현에 의한 도파민성 신경세포의 분화방법
WO2005003320A2 (en) * 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
EP1779867A4 (en) * 2004-07-01 2009-12-02 Eisai R&D Man Co Ltd MEANS FOR PROMOTING NERVE REVENERATION
WO2007119180A2 (en) * 2006-04-07 2007-10-25 Neuro Therapeutics Ab Survival and development of neural cells
EP1897937A1 (en) * 2006-09-07 2008-03-12 NeuroProgen GmbH Leipzig Method of culturing NPCs
CA2700573C (en) 2006-09-26 2016-11-22 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
CA2700436C (en) 2006-09-28 2017-04-18 John S. Yu Cancer vaccines and vaccination methods
PL2328923T3 (pl) 2008-09-02 2016-06-30 Cedars Sinai Medical Center Epitopy CD133
KR101181423B1 (ko) * 2009-01-30 2012-09-19 한양대학교 산학협력단 Ｎｕｒｒ1 변이체 발현을 이용한 개선된 도파민 신경세포의유도방법
EP2427485B1 (en) 2009-05-07 2016-12-07 ImmunoCellular Therapeutics, Ltd. Cd133 epitopes
KR101358601B1 (ko) 2011-12-30 2014-02-05 한양대학교 산학협력단 도파민 뉴런의 제조 방법
ES2662333T3 (es) 2013-02-14 2018-04-06 Immunocellular Therapeutics Ltd. Vacunas contra el cáncer y métodos de vacunación
JP6340216B2 (ja) 2014-03-07 2018-06-06 株式会社日立ハイテクノロジーズ 走査電子顕微鏡
KR102203034B1 (ko) * 2017-11-06 2021-01-14 한양대학교 산학협력단 중뇌 유래의 성상교세포와 도파민 신경줄기세포의 공동 이식에 의한 도파민 신경세포의 이식 치료 효과 개선
JP2019106895A (ja) * 2017-12-15 2019-07-04 インダストリー‐ユニバーシティー コーぺレーション ファンデーション ハンヤン ユニバーシティ 神経幹細胞または神経前駆細胞からドーパミン神経細胞への分化方法
CN111484977B (zh) * 2019-01-25 2023-05-16 中国科学院脑科学与智能技术卓越创新中心 重编程产生功能性去甲肾上腺素能神经元的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981165A (en) * 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
ES2167461T3 (es) 1994-09-23 2002-05-16 Neurospheres Holdings Ltd Modelos in vitro de funcion y disfuncion del sistema nervioso central.
US6284539B1 (en) * 1998-10-09 2001-09-04 Neuralstem Biopharmaceuticals, Ltd. Method for generating dopaminergic cells derived from neural precursors
US6312949B1 (en) 1999-03-26 2001-11-06 The Salk Institute For Biological Studies Regulation of tyrosine hydroxylase expression
WO2001088104A2 (en) 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
US20020114788A1 (en) 2000-07-27 2002-08-22 Ole Isacson Cell implantation therapy for neurological diseases or disorders

Also Published As

Publication number Publication date
EP1173548B1 (en) 2007-06-13
AU4752700A (en) 2000-11-17
DK1173548T3 (da) 2007-10-08
CA2371260A1 (en) 2000-11-09
US7465582B1 (en) 2008-12-16
ES2290032T3 (es) 2008-02-16
JP2002542818A (ja) 2002-12-17
WO2000066713A2 (en) 2000-11-09
DE60035191D1 (de) 2007-07-26
WO2000066713A3 (en) 2001-04-05
EP1173548A2 (en) 2002-01-23
ATE364688T1 (de) 2007-07-15

Similar Documents

Publication Publication Date Title
DE60035191T2 (de) Materialien und methoden zur entwicklung von dopaminergen neuronen
DE19756864C1 (de) Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten
Gage et al. Multipotent progenitor cells in the adult dentate gyrus
DE69233061T2 (de) Auf wachstumsfaktoren reagierende neurale vorläuferzellen, die in vitro vermehrt werden können.
Hartley et al. Functional synapses are formed between human NTera2 (NT2N, hNT) neurons grown on astrocytes
DE60225310T2 (de) Differenzierung vom gesamten knochenmark
DE69926639T2 (de) Knochenmarkszellen als quelle von neuronen zur wiederherstellung von gehirn und knochenmark
US7651853B2 (en) Cultures of GFAP+ nestin+ cells that differentiate to neurons
US6235527B1 (en) Lineage restricted glial precursors from the central nervous system
DE69924728T2 (de) Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung
Vick et al. Mitotic potential of adult rat oligodendrocytes in culture
Walter Triiodothyronine exerts a trophic action on rat sensory neuron survival and neurite outgrowth through different pathways
CN101679951B (zh) 端脑胶质限制性细胞群和相关组合物及方法
Zhang et al. Functional and histological improvement of the injured spinal cord following transplantation of Schwann cells transfected with NRG1 gene
CN118203665A (zh) 生成内耳毛细胞的方法
AU2004202661B2 (en) Materials and methods relating to neuronal development
JP2021084882A (ja) 脊髄損傷治療用ニューロスフェア誘導剤及びその使用
Mallorga et al. [3H] Diazepam binding sites on chick neurons in primary culture
Zhou et al. Regulation of Neural Stem Cells in the Adult Mammalian Brain
Wyatt The Physiological Relevance of hMNP Transplantation into the SMNdelta7 Murine Model of Spinal Muscular Atrophy
Saunders et al. Neural stem cells: Regulation and potential use in neuronal regeneration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee